| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Alam Kamran is a Chief Financial Officer at Taysha Gene Therapies, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $9.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | TSHA Taysha Gene Therapies, Inc. | Chief Financial Officer | Sell | 1,655 | $4.52 | $7,480.60 | -0.1% | +52.9% | - | |
| Aug 21, 2025 | TSHA Taysha Gene Therapies, Inc. | Chief Financial Officer | Sell | 54,491 | $2.85 | $155,299.35 | -4.4% | +39.7% | - | |
| Aug 24, 2023 | TSHA Taysha Gene Therapies, Inc. | Chief Financial Officer | Sell | 33,000 | $2.33 | $76,890.00 | -11.3% | -21.4% | -6.0% | |
| Aug 23, 2022 | TSHA Taysha Gene Therapies, Inc. | Chief Financial Officer | Sell | 3,325 | $3.47 | $11,537.75 | -1.2% | -36.0% | -36.0% | |
| Aug 22, 2022 | TSHA Taysha Gene Therapies, Inc. | Chief Financial Officer | Sell | 28,675 | $3.70 | $105,999.12 | -3.3% | -35.3% | -42.0% | |
| Aug 20, 2021 | TSHA Taysha Gene Therapies, Inc. | Chief Financial Officer | Sell | 33,000 | $16.88 | $557,022.56 | -2.1% | -18.5% | -77.9% |